Advancer Global Limited (SGX:43Q)

Elevation Oncology Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30	23	29	20	35	27
Market Cap Growth	-21.74%	-21.74%	43.75%	-42.03%	30.15%	-22.09%
Enterprise Value	7	5	11	-2	12	2
Last Close Price	0.12	0.09	0.12	0.08	0.14	0.10
PE Ratio	22.31	16.73	-	-	-	5.89
PS Ratio	0.47	0.35	0.44	0.32	0.58	0.47
PB Ratio	0.91	0.68	0.91	0.56	0.83	0.56
P/TBV Ratio	1.01	0.75	1.00	0.61	0.97	0.65
P/FCF Ratio	9.93	7.45	-	-	9.24	4.17
P/OCF Ratio	9.25	6.94	-	89.71	8.38	3.89
EV/Sales Ratio	0.11	0.08	0.17	-	0.20	0.03
EV/FCF Ratio	2.27	1.61	-	-	3.19	0.27
Debt / Equity Ratio	0.07	0.07	0.09	0.09	0.06	0.07
Debt / FCF Ratio	0.75	0.75	-	-	0.69	0.50
Asset Turnover	1.48	1.48	1.43	1.27	1.07	0.97
Inventory Turnover	97.61	97.61	63.44	63.47	53.56	43.65
Quick Ratio	3.78	3.78	2.92	3.75	4.18	4.03
Current Ratio	3.97	3.97	3.36	4.23	4.64	4.57
Return on Equity (ROE)	4.17%	4.17%	-12.44%	-12.03%	-9.21%	10.85%
Return on Assets (ROA)	-4.52%	-4.52%	-7.24%	-5.80%	-5.20%	-4.90%
Return on Capital (ROIC)	-5.63%	-5.63%	-8.89%	-6.89%	-6.14%	-5.76%
Earnings Yield	4.48%	5.98%	-13.62%	-22.00%	-11.67%	16.99%
FCF Yield	10.07%	13.43%	-9.12%	-1.41%	10.82%	24.00%
Dividend Yield	-	-	-	-	-	13.74%
Payout Ratio	-	-	-	-	-	32.77%
Buyback Yield / Dilution	-	-	-	0.00%	0.06%	0.00%
Total Shareholder Return	-	-	-	0.00%	0.06%	13.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.